Our work showed that out-of-range GGT contributed more in predicting AATD-LD disease progression than other laboratory parameters that are considered more reflective of liver metabolism and transport (total bilirubin); liver synthetic function (albumin), hepatocyte injury (AST); or cholestasis (alkaline phosphatase). This evidence concerns the gene ALB and alpha 1-antitrypsin deficiency.